
                     
                     
                     Drug Interactions
                     
                        No pharmacokinetic-based drug-drug interaction studies have been conducted with SYNAREL. However, because nafarelin acetate is a peptide that is primarily degraded by peptidase and not by cytochrome P-450 enzymes, and the drug is only about 80% bound to plasma proteins at 4Â°C, drug interactions would not be expected to occur.
                     
                     
                  
               